Literature DB >> 29694466

Computer-Aided Design/Computer-Assisted Manufacture-Derived Needle Guide for Injection of Botulinum Toxin into the Lateral Pterygoid Muscle in Patients with Oromandibular Dystonia.

Kazuya Yoshida.   

Abstract

AIMS: To evaluate the effectiveness and safety of botulinum toxin administration into the inferior head of the lateral pterygoid muscle of patients with jaw opening dystonia by using a computer-aided design/computer-assisted manufacture (CAD/CAM)-derived needle guide.
METHODS: A total of 17 patients with jaw opening dystonia were enrolled. After the patient's computed tomography (CT) scan was imported and fused with a scan of a plaster cast model of the maxilla, the optimal needle insertion site over the lateral pterygoid muscle was determined using the NobelClinician software. A total of 13 patients were injected both with and without the guide, and 4 patients underwent guided injection alone. The therapeutic effects of botulinum toxin injection and its associated complications were statistically compared between the guided and unguided procedures using paired t test.
RESULTS: Botulinum toxin therapy was performed 42 and 32 times with and without the guides, respectively. The needle was easily inserted without any complications in all procedures. There was a significant difference (P < .001) between the mean comprehensive improvements observed with (66.3%) and without (54.4%) the guides.
CONCLUSION: The findings suggest that the use of needle guides during the injection of botulinum toxin into the inferior head of the lateral pterygoid muscle is very useful for aiding the accurate and safe administration of botulinum toxin therapy for jaw opening dystonia.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29694466     DOI: 10.11607/ofph.1955

Source DB:  PubMed          Journal:  J Oral Facial Pain Headache


  12 in total

1.  Prevalence and incidence of oromandibular dystonia: an oral and maxillofacial surgery service-based study.

Authors:  Kazuya Yoshida
Journal:  Clin Oral Investig       Date:  2021-05-06       Impact factor: 3.573

2.  Ultrasound-guided lateral pterygoid muscle botulinum toxin: an injection for recurrent temporomandibular joint dislocation in a brain injury patient.

Authors:  Huai-Jing Guo; Chun-Chieh Wu; Tung-Chou Li
Journal:  Oral Maxillofac Surg       Date:  2022-04-29

Review 3.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

4.  Positioning accuracy assessment of minimally invasive percutaneous injection techniques for the treatment of temporomandibular disorders.

Authors:  Antônio Luís Neto Custódio; Andrew Cameron; Mahmoud Bakr; Chris Little; Bruno Ramos Chrcanovic; Peter Reher
Journal:  Dentomaxillofac Radiol       Date:  2020-07-24       Impact factor: 2.419

5.  Multilingual website and cyberconsultations for oromandibular dystonia.

Authors:  Kazuya Yoshida
Journal:  Neurol Int       Date:  2018-03-30

6.  Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2019-01-17       Impact factor: 4.546

Review 7.  Use of Botulinum Toxin in Orofacial Clinical Practice.

Authors:  Maria-Angeles Serrera-Figallo; Gonzalo Ruiz-de-León-Hernández; Daniel Torres-Lagares; Alejandra Castro-Araya; Omar Torres-Ferrerosa; Esther Hernández-Pacheco; Jose-Luis Gutierrez-Perez
Journal:  Toxins (Basel)       Date:  2020-02-11       Impact factor: 4.546

Review 8.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546

9.  Botulinum Neurotoxin Injection for the Treatment of Recurrent Temporomandibular Joint Dislocation with and without Neurogenic Muscular Hyperactivity.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2018-04-25       Impact factor: 4.546

10.  Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2021-08-29       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.